About rani therapeutics holdings inc - RANI
Rani Therapeutics Holdings, Inc. engages in the operation of a clinical stage bio-therapeutics company. The company was founded by Mir Imran on February 21, 2012 and is headquartered in San Jose, CA.
RANI At a Glance
Rani Therapeutics Holdings, Inc.
2051 Ringwood Avenue
San Jose, California 95131
| Phone | 1-408-457-3700 | Revenue | 1.63M | |
| Industry | Biotechnology | Net Income | -29,673,000.00 | |
| Sector | Health Technology | 2025 Sales Growth | 58.852% | |
| Fiscal Year-end | 12 / 2026 | Employees | 71 | |
| View SEC Filings |
RANI Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 54.676 |
| Price to Book Ratio | 3.992 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -1.395 |
| Enterprise Value to Sales | 31.964 |
| Total Debt to Enterprise Value | 0.083 |
RANI Efficiency
| Revenue/Employee | 23,000.00 |
| Income Per Employee | -417,929.577 |
| Receivables Turnover | 0.755 |
| Total Asset Turnover | 0.034 |
RANI Liquidity
| Current Ratio | 4.209 |
| Quick Ratio | 4.209 |
| Cash Ratio | 3.939 |
RANI Profitability
| Gross Margin | 44.887 |
| Operating Margin | -2,345.989 |
| Pretax Margin | -2,507.655 |
| Net Margin | -1,817.085 |
| Return on Assets | -62.302 |
| Return on Equity | -169.55 |
| Return on Total Capital | -79.493 |
| Return on Invested Capital | -116.401 |
RANI Capital Structure
| Total Debt to Total Equity | 13.081 |
| Total Debt to Total Capital | 11.568 |
| Total Debt to Total Assets | 7.366 |
| Long-Term Debt to Equity | 8.276 |
| Long-Term Debt to Total Capital | 7.319 |